BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22251881)

  • 1. Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies.
    Koshy M; Rich SE; Mahmood U; Kwok Y
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):619-25. PubMed ID: 22251881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
    LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
    Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy.
    Solanki AA; LeMieux MH; Chiu BC; Mahmood U; Hasan Y; Koshy M
    PLoS One; 2013; 8(9):e75336. PubMed ID: 24058675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
    Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease: study of treatment intensities and incidences of second malignancies.
    Rodriguez MA; Fuller LM; Zimmerman SO; Allen PK; Brown BW; Munsell MF; Hagemeister FB; McLaughlin P; Velasquez WS; Swan F
    Ann Oncol; 1993 Feb; 4(2):125-31. PubMed ID: 8448080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
    J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience.
    Lee CK; Aeppli D; Nierengarten ME
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):169-79. PubMed ID: 10924987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital.
    Cellai E; Magrini SM; Masala G; Alterini R; Costantini AS; Rigacci L; Olmastroni L; Papi MG; Spediacci MA; Innocenti F; Bellesi G; Ferrini PR; Biti G
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1327-37. PubMed ID: 11286841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
    Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
    Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
    J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Radiation Therapy on Survival in Hodgkin's Lymphoma: A SEER Data Analysis.
    Master S; Koshy N; Wilkinson B; Rosen L; Mills G; Mansour R; Shi R
    Anticancer Res; 2017 Jun; 37(6):3035-3043. PubMed ID: 28551642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the use of radiation therapy for early classical Hodgkin lymphoma in adolescents and young adults: implications for survival and second malignancies.
    Xavier AC; Costa LJ
    Leuk Lymphoma; 2015; 56(8):2339-43. PubMed ID: 25393805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
    Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital.
    Ganesan TS; Wrigley PF; Murray PA; Stansfeld AG; d'Ardenne AJ; Arnott S; Jones A; Shand WS; Malpas JS; Lister TA
    Br J Cancer; 1990 Aug; 62(2):314-8. PubMed ID: 2386750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.